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A B S T R A C T
Background: Contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention in
patients with ST-elevation myocardial infarction (STEMI) is a common complication associated with
worse outcome. Considering the prognostic predictive value of the red cell distribution width (RDW), we
aimed to measure the usefulness of RDW for predicting CI-AKI.
Methods: All consecutive STEMI patients without hemodialysis from June 2011 to September
2013 admitted to St. Luke’s International Hospital were enrolled. We performed primary percutaneous
coronary intervention in all patients. CI-AKI was deﬁned as a >25% increase or an absolute increase in
serum creatinine of 0.5 mg/dl within 3 days after percutaneous coronary intervention. The potential
additional predictive value of RDW with the Mehran risk score (MRS) on admission was estimated.
Results: A total of 102 patients (78.4% males) were analyzed – 10 of the 102 (10%) STEMI patients
developed CI-AKI. Multivariate analysis showed that RDW was an independent variable predicting CI-
AKI in these patients [odds ratio, 2.029; 95% conﬁdence interval (95% CI), 1.029–3.999; p = 0.041]. The
areas under the receiver operating characteristic curves for MRS only, RDW only, and the combined
model (MRS and RDW) for the prediction of CI-AKI were 0.806 (95% CI, 0.696–0.917), 0.719 (95% CI,
0.536–0.902), and 0.846 (95% CI, 0.744–0.949), respectively.
Conclusion: We showed the potential predictive ability of RDW, only if used with MRS, for CI-AKI in
STEMI patients. Further evaluation of RDW for predicting CI-AKI in patients with STEMI is needed.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Contrast-induced acute kidney injury (CI-AKI) is an important
complication of percutaneous coronary intervention (PCI) that
results in a poor long-term outcome [1]. The risk of CI-AKI was
reported to be higher in patients with acute myocardial infarction
than in patients undergoing elective PCI [2]. CI-AKI in acute
myocardial infarction is associated not only with short-term
mortality [3], but also with long-term mortality and morbidity [4].
Several risk scores to predict CI-AKI have been suggested. The
most commonly used risk score was that described by Mehran* Corresponding author at: Department of Cardiology, St. Luke’s International
Hospital, 9-1, Akashi-cho, Chuo-ku, Tokyo 104–0043, Japan. Tel.: +81 3 3541 5151;
fax: +81 3 3544 0649.
E-mail addresses: atmizu@luke.ac.jp, atmizu@gmail.com (A. Mizuno).
http://dx.doi.org/10.1016/j.jjcc.2014.09.006
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightset al. [5], which includes the following eight variables: hypoten-
sion, use of an intra-aortic balloon pump (IABP), congestive heart
failure, chronic kidney disease, diabetes, age >75 years, anemia,
and volume of contrast medium. However, there is no tailored risk
score for predicting CI-AKI especially in patients with acute
myocardial infarction. The Mehran risk score (MRS) had been
validated for the prediction of CI-AKI in patients with ST-elevation
myocardial infarction (STEMI) [6].
The red blood cell distribution width (RDW) has received
attention owing to its predictive usefulness in heart failure
patients [7,8]. Previous reports have mentioned the relation
between increased RDW and kidney injury [9]. However, there
is no study about the potential usefulness of RDW for predicting
CI-AKI in STEMI patients.
In this study, we investigated the additional utility of RDW for
predicting CI-AKI in STEMI patients. reserved.
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Patients
All consecutive STEMI patients without hemodialysis from June
2011 to September 2013 admitted to St. Luke’s International
Hospital were enrolled. We excluded eight patients lacking
laboratory data of RDW and creatinine. The deﬁnition of ST-
elevation was deﬁned as described previously (new ST-elevation at
the J-point in two contiguous leads) [10]. All patients were treated
according to the American College of Cardiology/American Heart
Association guidelines for the management of patients with ST-
elevation myocardial infarction and subjected to primary PCI
[11]. In all patients, PCI was performed with a nonionic low-
osmolality radiographic contrast agent.
Laboratory tests
We performed blood tests before contrast administration, every
4 h until the conﬁrmation of peak creatinine kinase, and within 48–
72 h later to detect the peak creatinine levels for deﬁning CI-AKI.
CI-AKI was deﬁned as a >25% increase or an absolute increase in
serum creatinine of 0.5 mg/dl within 3 days after PCI [12]. The risk
score for predicting CI-AKI was deﬁned as speciﬁed by Mehran
et al. [5] [hypotension, 5 points; use of IABP, 5 points; congestive
heart failure, 5 points; age >75 years, 4 points; anemia (baseline
hematocrit value, <39% for men and <36% for women), 3 points;
diabetes, 3 points; contrast medium volume, 1 for each 100 ml;
chronic kidney disease (serum creatinine >1.5 mg/dl or estimated
glomerular ﬁltration rate—eGFR: 20–40 ml min1 1.73 m2,
4 points; eGFR <40–60, 2 points; eGFR <20, 6 points)]. RDW
values at admission were also measured automatically by using an
XE-5000 automated hematology analyzer (Sysmex, Kobe, Japan)
[13].
Statistical analysis
Categorical variables were summarized as frequencies with
percentages, and were compared by Pearson chi-square analysis or
Fisher’s exact test. Continuous variables were compared by using
Student’s t-test for normally distributed values; otherwise, the
Mann–Whitney U-test was used. CI-AKI-related variables were
collected to determine signiﬁcant associations between age, sex,
MRS, and RDW. The prediction model for CI-AKI was developed on
the basis of multivariate logistic regression. The model was
validated through discrimination. Discrimination was assessed
with the receiver operating characteristic curve (ROC), area under
the ROC, sensitivity, and speciﬁcity. Finally, we ran the bootstrap
technique to assure the model ﬁtting for the prediction model.
Results
A total of 102 patients were analyzed – 10 of the 102 (10%)
STEMI patients developed CI-AKI. Table 1 shows the baseline
characteristics of our patients. CI-AKI patients were older than non
CI-AKI patients; however, the difference was not statistically
signiﬁcant. Baseline kidney function was worse (creatinine
2.6  4.3 mg/dl vs. 0.9  0.3 mg/dl, p < 0.001) and hemoglobin was
lower in CI-AKI patients (13.7  3 g/dl vs. 15.0  1.7 g/dl, p = 0.038).
The RDW was also signiﬁcantly higher in CI-AKI patients (14.2  1.7%
vs. 13.2  0.8%, p = 0.001). The culprit coronary artery distribution
and procedure variables were not different between two groups. The
MRS was signiﬁcantly higher in CI-AKI patients (10.9  5.0 vs.
5.6  4.7, p = 0.001).
Logistic regression analysis showed that the RDW was an
independent variable for predicting CI-AKI in these patients [oddsratio, 2.029; 95% conﬁdence interval (95% CI), 1.029–3.999;
p = 0.041] (Table 2).
The areas under the ROCs for the MRS, RDW, and the model
with both MRS and RDW for the prediction of CI-AKI were 0.806
(95% CI, 0.696–0.917), 0.719 (95% CI, 0.536–0.902), and 0.846 (95%
CI, 0.744–0.949), respectively (Fig. 1).
We used a bootstrap method to assess discrimination, in which
1000 random samples were drawn with replacement from the
original dataset, and the area under the ROC was recalculated for
each sample. The comparison between the bootstrapped model
and the simple logistic regression model showed a similar
regression coefﬁcient for each variable and similar area under
the ROC (c-index: 0.846 vs. 0.851, respectively, p = 0.102) (Table 3
and Fig. 2).
Discussion
CI-AKI in acute myocardial infarction is associated with short-
and long-term mortality and morbidity [4]. We demonstrated the
additional value of RDW when used with MRS for predicting CI-AKI
in STEMI patients.
CI-AKI and MRS
CI-AKI is a well-known complication after PCI, especially in
patients with acute myocardial infarction. After the development
of the simple risk score advocated by Mehran et al., several other
prediction models have been developed [14–16]. STEMI is one of
the important risk factors for CI-AKI after PCI [14]. CI-AKI is more
frequent in patients with STEMI and is associated with poor
prognosis. Therefore, CI-AKI in patients with STEMI should be
investigated separately. With regard to patients with STEMI,
another risk score for predicting CI-AKI has also been developed;
however, it included almost the same factors as with MRS, such as
the use of IABP, the contrast volume, and the patient’s age
[3]. Many clinicians consider MRS as a useful risk prediction model
even in patients with STEMI, and it has also been validated
previously. In our small number of STEMI patients, we also
observed a signiﬁcantly higher MRS in CI-AKI patients
(10.9  5.0 vs. 5.6  4.7) than in non-CI-AKI patients, and found
the usefulness of MRS for predicting CI-AKI (area under the ROC,
0.806). We used this simple risk score as a reference to verify the
additional value of RDW, and ﬁnally demonstrated that RDW has an
additional value in predicting CI-AKI in STEMI patients, especially
with the use of the MRS.
RDW and CI-AKI
The RDW expresses the variations in size of circulating
erythrocytes, and has received attention owing to its prognostic
value independent of age, sex, mean corpuscular volume, and
hemoglobin values [17]. As previously mentioned, RDW is used in
many clinical settings to predict poor outcome [7,18–21]. Although
the prognostic value of RDW in kidney disease has been
mentioned, there has been no previous study about the potential
predictive value of RDW for kidney injury [19].
Increased RDW means increased variability in red blood cell
size owing to ineffective erythrocyte production, which is
associated with indices of inﬂammation and pro-inﬂammatory
cytokines such as interleukin-6 [22]. On the other hand, suggested
mechanisms underlying CI-AKI include cytotoxic effects, factors
that affect renal hemodynamics, and regional hypoxia [23]. Related
to STEMI, low perfusion due to decreased cardiac output induces
ischemia, and systemic inﬂammation might affect both the
mechanism of increased RDW and CI-AKI. There has been no
previous report about the direct effect of RDW on kidney function.
Table 1
Patient characteristics.
CI-AKI, n = 10 Non-CI-CKI, n = 92 p value
Patient clinical data
Age (years) 68.9  17.3 60.4  13.6 0.069
Height (cm) 165.8  7.6 165.3  9.5 0.863
Weight (kg) 63.2  14.5 66.9  12.8 0.418
Male gender, n(%) 7(70) 73(80) 0.446
Smoking, n(%) 2(20) 49(53.3) 0.092
Past medical history
Hypertension, n(%) 7(70) 49(53.3) 0.505
Dyslipidemia, n(%) 1(10) 43(46.7) 0.040*
Diabetes, n(%) 1(10) 19(20.7) 0.682
Chronic kidney disease stage3 and more, n(%) 6(60.0) 24(26.1) 0.600
Old myocardial infarction, n(%) 1(10) 8(8.7) N.S.
Heart failure, n(%) 0(0) 1(1.1) N.S.
Cerebrovascular disease, n(%) 1(10) 7(7.6) 0.576
Peripheral arterial disease, n(%) 0(0) 5(5.4) N.S.
Chronic obstuctive lung disease, n(%) 0(0) 1(1.1) N.S.
Prior PCI 0(0) 9(9.8) 0.594
Cardiogenic shock, n(%) 3(30) 7(7.6) 0.057
Cardiopulmonary arrest, n(%) 1(10) 4(4.3) 0.41
Baseline laboratory results
Blood urea nitrogen (mg/dl) 42.5  21.9 15.2  7.3 <0.001*
eGFR (mL/min/1.73 m2) 46.7  24.7 74.7  23.8 0.001*
Hemoglobin (g/dl) 13.7  3 15.0  1.7 0.038*
Hematocrit (%) 41.2  7.5 43.6  4.5 0.143
MCHC (%) 33  1.6 34.3  0.9 0.029*
MCV (fL) 89.5  8.7 91.8  4.8 0.441
MCH (104/mL) 29.6  3.6 31.5  1.7 0.134
RDW (%) 14.2  1.7 13.2  0.8 0.001*
Platelet counts (109 L1) 213  57.5 226.8  73.7 0.569
MPV (fL) 10.2  0.7 10.1  0.8 0.640
Creatinine baseline (mg/dl) 2.6  4.3 0.9  0.3 <0.001*
Creatinine within 48–72 h (mg/dl) 3.7  5.3 0.8  0.2 <0.001*
Coronary artery distribution 0.129
LAD, n(%) 7(70) 50(54.3)
RCA, n(%) 2(20) 31(33.7)
LCX, n(%) 0(0) 10(10.9)
LMT, n(%) 1(10) 1(1.1)
Procedure
Door to balloon time (min) 82.6  28.2 114.6  87.5 0.255
Fluoroscopy time (min) 33.1  16.8 33.8  18.6 0.961
Contrast volume (ml) 215.3  132.1 217.7  70.6 0.957
Use of intravascular ultrasound, n(%) 9(90) 85(92.4) 0.576
Use of intravascular aortic balloon pumping, n(%) 3(30) 17(18.5) 0.407
Mehran risk score 10.9  5.0 5.6  4.7 0.001*
CI-AKI, contrast-induced acute kidney injury; PCI, percutaneous coronary intervention; eGFR, estimated glomerular ﬁltration rate; MCV, mean corpuscular volume;
MCHC, mean corpuscular hemoglobin concentration; MCH, mean corpuscular hemoglobin; RDW, red blood cell distribution width; MPV, Mean platelet volume; LAD, left
anterior descending artery; RCA, right coronary artery; LCX, left circumﬂex artery; LMT, left main trunk; N.S., not signiﬁcant.
* p < 0.05.
Table 2
Logistic regression model.
Odds ratio 95% CI p value
MRS 1.167 1.032–1.319 0.014
RDW 2.029 1.029–3.999 0.041
Constant 0 0.006
MRS, Mehran risk score; RDW, red blood cell distribution width.
Table 3
Model comparison after bootstrapping.




MRS 0.154 0.154–0.277 0.168 0.029–0.318
RDW 0.708 0.708–1.386 0.842 0.009–2.047
Constant 13.06 13.06 15.139 32.486 to 3.947
MRS, Mehran risk score; RDW, red blood cell distribution width.
A. Mizuno et al. / Journal of Cardiology 66 (2015) 41–45 43However, it is reasonable to consider RDW as a surrogate maker of
inﬂammation, which might have an additional predictive value for
CI-AKI. RDW has been considered to be an index of a chronic phase,
which is correlated with oxidative stress and inﬂammation.
Patients with an increased RDW may have a high level of oxidative
stress and chronic inﬂammation, which could lead to renal
dysfunction after PCI.
As mentioned above, we consider MRS as a useful score for
predicting CI-AKI even in patients with STEMI. Therefore, our study
mainly focused on the additional value of RDW, which was
investigated by comparing the area under the ROCs. Because our
sample size was small, we also evaluated the model’s performance
by using bootstrapping methods. There was no signiﬁcant change
in the models between before and after bootstrapping. Therefore,
we have conﬁrmed the preciseness of our prediction model.
In clinical practice, MRS is usually used to predict CI-AKI after
PCI. Our results might help clinicians realize the usefulness of RDW
as a predictive guide, especially in patients with STEMI [24]. Fur-
ther evaluation of the predictive value of RDW for CI-AKI in larger






















Fig. 2. Receiver operating characteristics (ROC) curves of the prediction model and
the bootstrapped prediction model for detecting CI-AKI in STEMI patients. The area
under the receiver operating characteristics curve for the original prediction model
and the bootstrapped prediction model for detecting CI-AKI was 0.846 and 0.851,
respectively. CI-AKI, contrast-induced acute kidney injury; STEMI, ST-segment


















Fig. 1. Receiver operating characteristic (ROC) curves of MRS only, RDW only, and
the prediction model with both MRS and RDW, for detecting CI-AKI in STEMI
patients. The area under the curve for MRS was 0.806 (95% CI, 0.696–0.917); for
RDW, 0.719 (95% CI, 0.536–0.902); and for the prediction model, 0.846 (95% CI,
0.744–0.949). MRS, Mehran risk score; RDW, red blood cell distribution width; CI-
AKI, contrast-induced acute kidney injury; STEMI, ST-segment elevated myocardial
infarction.
A. Mizuno et al. / Journal of Cardiology 66 (2015) 41–4544investigated because of its availability as part of the cell blood
count test that is routinely performed in general patient
evaluations. With this tool, there is no need to perform other
additional tests to check the inﬂammatory score.
Limitations
A novel ﬁnding about the additional property of RDW was
reached in this study; however, there are several limitations. First,
we included only 100 patients. This number is small to deﬁnitely
conﬁrm the predictive value of RDW. Therefore, we not only
performed logistic regression analysis but also evaluated the
model’s preciseness by using bootstrapping methods. We could
not conclude that RDW is independently important in predicting
CI-AKI only by the results of this study; however, they show thepossibility. Our purpose is to evaluate the potential usefulness of
RDW for predicting CI-AKI in patients with STEMI. Second, we
could not exclude potential confounding factors of RDW such as
age, anemia, and kidney function. Previous studies have already
shown the independent importance of RDW in other clinical
settings; however, we could not conﬁrm this only with our results.
Further large-scale data are needed to conﬁrm the usefulness of
RDW.
Conclusion
We showed the potential predictive ability of RDW, only if used
with MRS, for CI-AKI in STEMI patients. Further evaluation of RDW
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